Fundamental Analysis
19 / 100CRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -376.3% | -510.2% | 0 / 3 | -39.9% | -19.40 pp | -14.83 pp | -12.2% | 0.47 | — | 94,5 | −39,9% | −11,5 | −376,3% | — | 24.44 | — |
| Pts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12 | 8 | |||||||
Valuation annotation:Price: 22.600 (close price on 2026-10-12)EPS (TTM): −3.485,1
Financial charts
1.Revenue & growth
VND bn94,5Q2/26
1.Revenue & growth
VND bn94,5Q2/26
2.Profit & growth
VND bn-11,5Q2/26
3.Profit mix (Penman)
VND bn-12,9Q2/26
4.Margins & cost structure
%14.9%Q2/26
5.Returns & cash cycle
% · days-4.6%Q2/26
6.Earnings quality & cash
VND bn25,7Q2/26
7.Asset structure
VND bn268Q2/26
8.Funding & debt health
VND bn · times268Q2/26
9.Revenue backlog
VND bn18,7Q2/26
10.Valuation
times · %-5,8×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %-2.303Q2/26
Adjusted EPS growth, latest quarter
-376%
Average adjusted EPS growth, 3 quarters
-300%
averaged over 2 quarter(s)
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26